Signalling via caveolin: Involvement in the cross-talk between phosphoinositolglgcans and insulin

Cellular and Molecular Life Sciences

Volumn 56, Issue 11-12, 1999, Pages 945-970

  Muller G ^a   Frick, W ^a  

^a SANOFI   (France)

Author keywords

Caveolin; Detergent insoluble glycolipid enriched rafts; Glycosyl phosphatidylinositol; Insulin receptor and signalling; Insulin receptor substrate proteins; Insulin resistance

Indexed keywords

CAVEOLIN; GLYCOSYLPHOSPHATIDYLINOSITOL; INSULIN; INSULIN RECEPTOR;

INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CAVEOLAE; CAVEOLINS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INSULIN; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE KINASES; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

ANIMALIA;

EID: 0033396913     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050485     Document Type: Review

References (178)

1. 1 Czech M. P. and Corvera S. (1999) Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 274: 1865 1868
2. 2 Pessin J. E., Thurmond D. C., Elmendorf J. S., Coker K. J. and Okada S. (1999) Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. J. Biol. Chem. 274: 2593 2596
3. 3 Le Marchand-Brustel Y., Tanti J.-F., Cormont M., Ricort J.-M., Gremeaux T. and Grillo S. (1999) From insulin receptor signalling to GLUT4 translocation abnormalities in obesity and insulin resistance. J. Rec. Signal Transduc. Res. 19: 217-228
4. 4 Myers M. G. and White M. F. (1995) New frontiers in insulin receptor substrate signaling. Trends Endocrinol. Metab. 6: 209 215
5. 5 White M. F. (1998) The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182: 3-11
6. 6 Saltiel A. R. (1996) Diverse signaling pathways in the cellular actions of insulin. Am. J. Physiol. 270: 375-385
7. 7 Yenush L. and White M. F. (1997) The IRS-signalling system during insulin and cytokine action. Bioessays 19: 491-500
8. 8 White M. F. (1996) The IRS-signalling system in insulin and cytokine action. Phil. Trans. R. Soc. Lond. B 351: 181-189
9. 9 White M. F. (1997) The insulin signalling system and the IRS proteins. Diabetologia 40: S2-S17
10. 10 Holman G. D. and Kasuga M. (1997) From receptor to transporter: insulin signalling to glucose transport. Diabetologia 40: 991-1003
11. 11 Gustafson T. A., Moodie S. A. and Lavan B. E. (1998) The insulin receptor and metabolic signaling. In: Reviews in Physiology, Biochemistry and Pharmacology, vol. 137, pp. 71-192, Blaustein P., Greger M., Grunicke S., Jahn P., Lederer G., Mendell A., Miyajima T. U., Pette U., Schultz F., Schweiger M. (eds), Springer, Berlin
12. 12 Velloso I. A., Folli F., Sun X.-U., White M. F., Saad M. J. A. and Kahn C. R. (1996) Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. USA 93: 12490-12495
13. 13 Frevet E. U. and Kahn B. B. (1997) Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol. Cell. Biol. 17: 190-198
14. 14 Okada T., Kawano Y., Sakakibara T., Hazeki O. and Ui M. (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and anti-lipolysis in rat adipocytes. J. Biol. Chem. 269: 3568 3573
15. 15 Katagiri H., Asano T., Inukai K., Ogihara T., Ishihara H., Shibasaki Y. et al. (1997) Roles of PI 3-kinase and Ras on insulin-stimulated glucose transport in 3T3-L1 adipocytes. Am. J. Physiol. 272: E326 E331
16. 16 Nave B. T., Haigh R. J., Hayward A. C., Siddle K. and Shepherd P. (1996) Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem. J. 318: 55 60
17. 17 Cheatham R. B., Vlahos C. J., Cheatham L., Wang L., Blenis J. and Kahn C. R. (1994) Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14: 4902 4911
18. 18 Herbst J. J., Andrews G. C., Contillo L. G., Singleton P. H., Genereux P. E., Gibbs E. M. et al. (1995) Effect of the activation of phosphatidylinositol 3-kinase by a thiophosphotyrosine peptide on glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 270: 26000 26005
19. 19 Yeh J. I., Gulve E. A., Rameh L. and Birmbaum M. J. (1997) The effects of wortmannin on rat skeletal muscle: dissociation of signalling pathways for insulin- and contraction-activated hexose transport. J. Biol. Chem. 270: 2107 2111
20. 20 Alessi D. R. and Downes C. P. (1998) The role of PI 3-kinase in insulin action. Biochim. Biophys. Acta 1436: 151 164
21. 21 Shepherd P. R., Withers D. J. and Siddle K. (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333: 471 490
22. 22 Burgering B. M. and Coffer P. J. (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599 602
23. 23 Hurel S. J., Rochford J. J., Borthwick A. C., Wells A. M., Vandenheede J R., Turnbull D. M. et al. (1996) Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem. J. 320: 871-877
24. 24 Shepherd P. R., Nave B. T., Rincon J., Haigh R. J., Foulstone E., Proud C. et al. (1997) Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia 40: 1172 1177
25. 25 Marte B. M. and Downward J. (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22: 355 358
26. 26 Meier R. and Hemmings B. A. (1999) Regulation of protein kinase B. J. Rec. Signal Transduc. Res. 19: 121 128
27. 27 Coffer P. J., Jin J. and Woodgett J. R. (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidyl 3-kinase activation. Biochem. J. 335: 1 13
28. 28 Cohen P., Alessi D. R. and Cross D. A. E. (1997) PDK 1, one of the missing links in insulin signal transduction? FEBS Lett. 410: 3 10
29. 29 Plyte S. E., Hughes K., Nikolakaki E., Pulverer B. J. and Woodgett J. R. (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114: 147 162
30. 30 Moule S. K., Welsh G. I., Edgell N. J., Foulstone E. J., Proud C. G. and Denton R. M. (1997) Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells: activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272: 7713-7719
31. 31 Bollen M. and Stalmans W. (1992) The structure, role and, regulation of type 1 protein phosphatases. Crit. Rev. Biochem. Mol. Biol. 27: 227 281
32. 32 Welsh G. I. and Proud C. G. (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. 294: 1 4
33. 33 Eldar-Finkelman H. and Krebs E. G. (1997) Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl. Acad. Sci. USA 94: 9660 9664
34. 34 Lam K., Carpenter C. L., Ruderman N. B., Friel J. C. and Kelly K. L. (1994) The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1: stimulation by insulin and inhibition by wortmannin. J. Biol. Chem. 269: 20648 20652
35. 35 Yamauchi K., Holt K. and Pessin J. E. (1993) Phosphatidylinositol 3-kinase functions upstream of Ras and Raf in mediating insulin stimulation of c-fos transcription. J. Biol. Chem. 268: 14597 14600
36. 36 Rodriguez-Viciana P., Warne P. H., Vanhaesebroeck B., Waterfield M. D. and Downward J. (1996) Activation of phosphoinositide 3-kinase by interaction with Ras and point mutation. EMBO J. 15: 2442 2451
37. 37 Mueller G., Ertl J., Gerl M. and Preibisch G. (1997) Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J. Biol. Chem. 272: 10585 10593
38. 38 Häring H.-U. (1991) The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34: 848 861
39. 39 Kahn C. R. (1994) Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066 1084
40. 40 Nystrom F. H. and Quon M. J. (1999) Insulin signalling: metabolic pathways and mechanisms for specificity. Cell. Signal. 11: 563 574
41. 41 Ricort J. M., Tanti J. F., Van Obberghen E. and Le Marchand-Brustel Y. (1997) Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes. J. Biol. Chem. 272: 19814 19818
42. 1 signaling pathways. J. Biol. Chem. 273: 22899-22903
43. 43 Vuori K. and Ruoslahti E. (1994) Association of insulin receptor substrate-1 with integrins. Science 266: 1576 1579
44. 44 Romero G. and Larner J. (1993) Insulin mediators and the mechanism of insulin action. Adv. Pharmacol. 24: 21-50
45. 45 Jarett L., Kiechle F. L., Macaulay S. L., Parker J. C. and Kelly K. L. (1985) Intracellular mediators of insulin action. In: Molecular Basis of Insulin Action, pp. 171-182, Cech M. P. (ed.), Plenum, New York
46. 46 Saltiel A. R., Fox J. A., Sherline P. and Cuatrecasas P. (1986) Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Science 233: 967 972
47. 47 Mato J. M., Kelly K. L., Abler A. and Jarett L. (1987) Partial structure of an insulin-sensitive glycophospholipid. J. Biol. Chem. 262: 2131 2137
48. 48 Mato J. M., Kelly K. L., Abler A., Jarett L., Corkey B. E., Cashel J. A. et al. (1987) Partial structure of an insulin-sensitive glycophospholipid. Biochem. Biophys. Res. Commun. 146: 764 770
49. 49 Saltiel A. R. (1990) Second messengers of insulin action. Diabetes Care 13: 244 256
50. 50 Varela-Nieto I., Leon Y. and Caro H. N. (1996) Cell signalling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. 115B: 223 241
51. 51 Jones D. R. and Varela-Nieto I. (1998) The role of glycosyl-phosphatidylinositol in signal transduction. Int. J. Biochem. Cell Biol. 30: 313 326
52. 52 Low M. G. and Saltiel A. R. (1988) Structural and functional roles of glycosyl-phosphatidylinositol in membranes. Science 239: 268-275
53. 53 Cross G. A. M. (1990) Glycolipid anchoring of plasma membrane proteins. Annu. Rev. Cell Biol. 6: 1-39
54. 54 McConville M. J. and Ferguson M. A. J. (1993) The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294: 305-324
55. 55 Nosjean O., Briolay A. and Roux B. (1997) Mammalian GPI proteins: sorting, membrane residence and functions. Biochim. Biophys. Acta 1331: 153 186
56. 56 Huang L. C., Heimark D., Linko J., Nolan R. and Larner J. (1999) A model phosphatase 2C → phosphatasc 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylalion by two inositol glycan putative insulin mediators from beef liver. Biochem. Biophys. Res. Commun. 255: 150-156
57. 3HI cells. Proc. Natl. Acad. Sci. USA 87: 1476 1480
58. 58 Lazar D. F., Knez J. J., Medof M. E., Cuatrecasas P. and Saltiel A. R. (1994) Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosyl-phosphatidylinositol. Proc. Natl. Acad. Sci. USA 91: 9665-9669
59. 59 Fonteles M. C., Huang L. C. and Larner J. (1996) Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycemia. Diabetologia 39: 731-734
60. 60 Asplin I., Galasko G. and Larner J. (1993) Chiro -inositol deficiency and insulin resistance: a comparison of the chiro-inositol and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc. Natl. Acad. Sci. USA 90: 5924 5928
61. 61 Shashkin P. N., Shashkina E. F., Fernqvist-Forbes E., Zhou Y.-P., Grill V. and Katz A. (1997) Insulin mediators in man: effects of glucose and insulin resistance. Diabetologia 40: 557 563
62. 62 Müller G., Dearey E.-A., Korndörfer A. and Bandlow W. (1994) Stimulation of a glycosyl phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport. J. Cell Biol. 126: 1267 1276
63. 63 Farese R. V. (1990) Lipid-derived mediators in insulin action. Proc. Soc. Exp. Biol. Med. 195: 312 324
64. 64 Gaulton G. N. and Pratt J. C. (1994) Glycosylated phosphatidylinositol molecules as second messengers. Semin. Immunol. 6: 97 104
65. 65 Romero G. L., Luttrell L., Rogol A., Zeller K., Hewlett E. and Larner J. (1988) Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science 240: 509-511
66. 66 Müller G., Dearey E.-A. and Pünter J. (1993) The sulfonylurea drug, glimepiride, stimulates release of glycosyl-phosphatidylinositol-anchored plasma membrane proteins from 3T3 adipocytes. Biochem. J. 289: 509 521
67. 67 Movahedi S. and Hooper N. M. (1997) Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C. Biochem. J. 326: 531 537
68. 68 Larner J. (1987) Banting lecture. Insulin signaling mechanisms: lessons from the old testament of glycogen metabolism and the new testament of molecular biology. Diabetes 37: 262-275
69. 69 Saltiel A. R., Osterman D. G., Darnell J. C., Sorbara-Cazan L. R., Chan B. L., Low M. G. et al. (1988) The function of glycosyl phosphoinositides in hormone action. Phil. Trans. R. Soc. Lond. B 320: 345-358
70. 70 Mato J. M. (1989) Insulin mediators revisited. Cell. Signal. 1: 143-146
71. 71 Misek D. E. and Saltiel A. R. (1992) An inositol phosphate glycan derived from Trypanosoma brucei glycosyl-phosphatidylinositol mimics some of the metabolic actions of insulin. J. Biol. Chem. 267: 16266 16273
72. 72 Deeg M. A., Brass E. P. and Rosenberry T. L. (1993) Inositol glycan phosphate derived from human erythrocyte acetylcholinesterase glycolipid anchor and inositol cyclic 1,2-phosphate antagonize glucagon activation of glycogen phosphorylase. Diabetes 42: 1318-1323
73. 73 Müller G., Wied S., Crecelius A., Kessler A. and Eckel J. (1997) Phosphoinositolglycan-peptides from yeast potently induce metabolic insulin actions in isolated rat adipocytes, cardiomyocytes, and diaphragms. Endocrinology 138: 3459-3475
74. 74 Müller G., Schubert K., Fiedler F. and Bandlow W. (1992) The cAMP-binding ectoprotein from Saccharomyces cerevisiae is membrane-anchord by glycosyl-phosphatidylinositol. J. Biol. Chem. 267: 25337-25346
75. 75 Müller G., Wetekam E.-M., Wied S. and Bandlow W. (1994) Membrane association of lipoprotein lipase and a cAMP-binding ectoprotein in rat adipocytes. Biochemistry 33: 12149-12159
76. 76 Müller G. and Bandlow W. (1993) Glucose induces lipolytic cleavage of a glycolipidic plasma membrane anchor in yeast. J. Cell Biol. 122: 325 336
77. 77 Kessler A., Müller G., Wied S., Crecelius A. and Eckel J. (1998) Signalling pathways of an insulin-mimetic phosphoinositolglycan-peptide in muscle and adipose tissues. Biochem. J. 330: 277-286
78. 78 Müller G., Wied S., Piossek C., Bauer A., Bauer J. and Frick W. (1998) Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. Mol. Med. 4: 299-323
79. 79 Frick W., Bauer A., Bauer J., Wied S. and Müller G. (1998) Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action. Biochemistry 38: 13421 13436
80. 80 Frick W., Bauer A., Bauer J., Wied S. and Müller G. (1998) Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes. Biochem. J. 336: 163 181
81. 81 Uddin S., Yenush L., Sun X.-J., Sweet M. E., White M. F. and Platanias L. C. (1995) Interferon-x engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol. Chem. 270: 15938 15941
82. 82 Johnston J. A., Wang L.-M., Hanson E. P., Sun X.-J., White M. F., Oakes S. A. et al. (1995) Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. J. Biol. Chem. 270: 28527-28530
83. 83 Saad M. J. A., Velloso L. A. and Carvalho C. R. O. (1995) Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem. J. 310: 741 744
84. 84 Velloso I. A., Folli F., Sun X. J., White M. F., Saad M. J. A. and Kahn C. R. (1996) Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. USA 93: 12490 12495
85. 85 Kowalski-Chauvel A., Pradayrol L., Vaysse N. and Seva C. (1996) Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase. J. Biol. Chem. 271: 26356 26361
86. 86 Argetsinger L. S., Hsu G. W., Myers M. G., Billestrup N., White M. F. and Carter-Su C. (1995) Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270: 14685 14692
87. 87 Verdier F., Chretien S., Billat C., Gisselbrecht S., Lacombe C. and Mayeux P. (1997) Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. J. Biol. Chem. 272: 26173 26178
88. 88 Brown D. A. and Rose J. K. (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533 544
89. 89 Brown D. A. and London E. (1997) Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240: 1 7
90. 90 Anderson R. G. W. (1993) Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. USA 90: 10909 10913
91. 91 Anderson R. G. W. (1993) Plasmalemmal caveolae and GPI-anchored membrane proteins. Curr. Opin. Cell Biol. 5: 647 652
92. 92 Parton R. G. (1996) Cavcolae and caveolins. Curr. Opin. Cell Biol. 8: 542-548
93. 93 Rothberg K. G., Henser J. E., Donzell W. C., Ying Y.-S., Glenney J. R. and Anderson R. G. W. (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68: 673 682
94. 94 Kurzchalia T. V., Dupree P. and Monier S. (1994) VIP-21 caveolin, a protein of the trans-Golgi network and caveolae. FEBS Lett. 346: 88-91
95. 95 Scherer P. E., Lisanti M. P., Baldini G., Sargiacomo M., Mastick C. C. and Lodish H. F. (1994) Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 127: 1233 1243
96. 96 Das K., Lewis R. Y., Scherer P. E. and Lisanti M. P. (1999) The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. J. Biol. Chem. 274: 18721-18728
97. 97 Sargiacomo M., Scherer P. E., Tang Z., Kübler E., Song K. S., Sanders M. C. et al. (1995) Oligomeric structure of caveolin: implications for caveolae membrane organizations. Proc. Natl. Acad. Sci. USA 92: 9407 9411
98. 98 Lisanti M. P., Scherer P. E., Tang Z. L. and Sargiacomo M. (1994) Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol. 4: 231-235
99. 99 Schlegel A., Volonte D., Engelman J. A., Galbiati F., Mehta P., Zhang X.-L. et al. (1998) Crowded little caves: structure and function of caveolac. Cell. Signal. 10: 457 463
100. 100 Okamoto T., Schlegel A., Scherer P. E. and Lisanti M. P. (1998) Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J. Biol. Chem. 273: 5419-5422
101. 101 Anderson R. G. W. (1998) The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225
102. 102 Bickel P. E., Scherer P. E., Schnitzer J. E., Oh P., Lisanti M. P. and Lodish H. F. (1997) Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 272: 13793 13802
103. 103 Volonte D., Galbiati F., Li S., Nishiyama K., Okamoto T. and Lisanti M. P. (1999) Flotillins/cavatellins are differentially expressed in cells and tissues and form a heterooligomeric complex with caveolins in vivo. J. Biol. Chem. 274: 12702-12709
104. 104 Milligan G., Parenti M. and Magee A. L. (1995) The dynamic role of palmitoylation in signal transduction. Trends Biochem. Sci 20: 181 186
105. 105 Harder T. and Simons K. (1997) Caveolae, DIGs, and the dynamics of sphingolipid-choleslerol microdomains. Curr. Opin. Cell Biol. 9: 534 542
106. 106 Stefanova I. V., Horejsi V., Ansotegui I. J., Knapp W. and Stockinger H. (1991) GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254: 1016 1019
107. 107 Su B., Waneck G. L., Flavell R. A. and Bothwell A. L. M. (1991) The glycosylphosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation. J. Cell Biol. 112: 377-384
108. 108 Shenoy-Scaria A. M., Dietzen D. J., Kwong J., Link D. C. and Lublin D. M. (1994) Cysteine of Sre family protein tyrosine kinases determines palmitoylation and localization in caveolae. J. Cell Biol. 126: 353 363
109. 109 Rodgers W., Crise B. and Rose J. K. (1994) Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol. Cell. Biol. 14: 5384 5391
110. 110 Robbins S. M., Quintrell N. A. and Bishop J. M. (1995) Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Mol. Cell. Biol. 15: 3507 3515
111. 111 Ying Y.-S., Anderson R. G. W. and Rothberg K. G. (1992) Each caveolae contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harbor Quant. Biol. 57: 593 604
112. 112 Muruta M., Kurzchalia T., Peranen J., Schreiner R., Wieland F. T., Kurzchalia T. et al. (1995) VIP21-caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 92: 10339 10343
113. 113 Fra A. M., Williamson E., Simons K. and Parton R. G. (1995) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. USA 92: 8655 8659
114. 114 Song K. S., Scherer P. E., Tang Z., Okamoto T., Li S., Chafel M. et al. (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J. Biol. Chem. 271: 15160 15165
115. 115 Parpal S., Gustavsson J. and Stralfors S. (1995) Isolation of phosphooligosaccharide/phosphoinositolglycan from caveolae and cytosol of insulin-stimulated cells. J. Cell Biol. 131: 125 135
116. 116 Gustavsson J., Parpal S. and Stralfors S. (1996) Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane. Mol. Med. 2: 367-372
117. 117 Kandror K. V., Stephens J. M. and Pilch P. F. (1995) Expression and compartmentalization of caveolin in adipose cells: coordinate regulation with and structural segregation from GLUT4. J. Cell Biol. 129: 999 1006
118. 118 Munoz P., Mora S., Sevilla L., Kaliman P., Tomas E., Guma A. et al. (1996) Expression and insulin-regulated distribution of caveolin in skeletal muscle. J. Biol. Chem. 271: 8133 8139
119. 119 Smith R. M., Harada S., Smith J. A., Zhang S. and Jarett L., (1998) Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain. Cell. Signal. 10: 355 362
120. 120 Mastick C. C, Brady M. J. and Saltiel A. R. (1995) Insulin stimulates the tyrosine phosphorylation of caveolin. J. Cell Biol. 129: 1523 1531
121. 121 Müller G. and Geisen K. (1996) Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes. Horm. Metab. Res. 28: 469 487
122. 122 Brown M. T. and Cooper J. A. (1996) Regulation, substrates and function of src. Biochim. Biophys. Acta 1287: 121 149
123. 123 Resh M. D. (1998) Fyn, a Src family tyrosine kinase. Int. J. Biochem. Cell Biol. 30: 1159 1162
124. 124 Müller G., Welte S., Bauer A. and Frick W. (1999) Interaction of caveolin and non-receptor tyrosine kinases as target for insulin-mimetic compounds (abstract). Diabetes 48(suppl. I): A219 A220
125. 125 Sun X. J., Pons S., Asano T., Myers M. G., Glasheen E. and White M. F. (1996) The fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271: 10583-10587
126. 126 Tachado S. D. and Schofield L. (1994) Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-Ix and TNF-x expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem. Biophys. Res. Commun. 205: 984 991
127. 127 Luttrell L. M., Hawes B. E., Biesen T. van, Luttrell D. K., Lansing T. J. and Lefkowitz R. J. (1996) Role of c-Src tyrosine kinase in G protein-coupled receptor-and Gβγ-subunit-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 271: 19443 19450
128. 2-adrenergic receptor-Src protein kinase complexes. Science 283: 655 661
129. src. J. Biol. Chem. 273: 32244 32253
130. FAK in the insulin-mimetic signaling of phosphoinositol-glycan compounds in adherent/non-adherent adipocytes (abstract). Diabetologia 42 (Suppl. 1): A66
131. 131 Wary K. K., Mariotti A., Zurzolo C. and Giancotti F. G. (1998) A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94: 625 634
132. 132 Longhurst C. M. and Jennings L. K. (1998) Integrin-mediated signal transduction. Cell. Mol. Life Sci. 54: 514 526
133. 133 Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J. E., Hansen S. H. et al. (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270: 15693 15701
134. x subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the autoactivation of Src tyrosine kinases. J. Biol. Chem. 271: 29182 29190
135. 135 Song K. S., Li S., Okamoto T., Quilliam L., Sargiacomo M. and Lisanti M. P. (1996) Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271: 9690 9697
136. 136 Couet J., Li S., Okamoto T., Ikezu T. and Lisanti M. P. (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. J. Biol. Chem. 272: 6525-6533
137. 137 Couet J., Sargiacomo M. and Lisanti M. P. (1997) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: caveolin binding negatively regulates tyrosine and serine/ threonine kinase activities. J. Biol. Chem. 272: 6525-6533
138. 138 Engelman J. A., Lee R. J., Karnezis A., Bearss D. J., Webster M., Siegel P. et al. (1998) Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo: implications for human breast cancer. J. Biol. Chem. 273: 20448-20455
139. 139 Oka N., Yamamoto M., Schwencke C., Kawabe J., Ebina T., Couet J. et al. (1997) Caveolin interaction with protein kinase C: isoenzyme-dependent regulation of kinase activity by the caveolin-scaffolding domain peptide. J. Biol. Chem. 272: 33416 33421
140. 140 Yamamoto M., Toya Y., Schwencke C., Lisanti M. P., Myers M. G. and Ishikawa (1998) Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 273: 26962-26968
141. il is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. J. Biol. Chem. 274: 5843 5850
142. 142 Garcia-Cardena G., Oh P., Liu J., Schnitzer J. E. and Sessa W. C. (1996) Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA 93: 6448-6453
143. 143 Engelman J. A., Chu C., Lin A., Jo H., Ikezu T., Okamoto T. et al. (1998) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo: a role for the caveolin-scaffolding domain. FEBS Lett. 428: 205-211
144. 144 Müller G., Welte S., Wied S., Bauer J. and Frick W. (1999) Redistribution of glycosyl-phosphatidylinositol-anchored proteins from caveolae as potential target for signal transduction therapy (abstract). Eur. J. Cell Biol. 78(suppl. 49): 73
145. 145 Müller G., Welte S., Wied S. and Frick W. (1999) Phosphoinositolglycan-(peptides) mimicking metabolic insulin signaling cause redistribution of glycosyl-phosphatidylinositol-anchored proteins from caveolae (abstract). Biol. Chem. Hoppe-Seyler 379 (spec. suppl.): S104
146. 146 Kim J. H., Han J. M., Lee S., Kim Y., Lee T. G., Park J. B. et al. (1999) Phospholipase D1 in caveolae: regulation by protein kinase Cx and caveolin-1. Biochemistry 38: 3763-3769
147. 147 Glenney J. R. and Soppet D. (1992) Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA 89: 10517 10521
148. fyn protein tyrosine kinase in T cells. J. Biol. Chem. 267: 12317-12322
149. 149 Smart E. J., Ying Y.-S., Donzell W. C. and Anderson R. G. W. (1996) A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271: 29427-29435
150. 150 Chang W.-J., Rothberg K. G., Kamen B. A. and Anderson R. G. W. (1992) Lowering the cholesterol content of MA 104 cells inhibits receptor-mediated transport of folate. J. Cell Biol. 118: 63 69
151. 151 Baorto D. M., Gao Z., Malaviya R., Dustin M. L., Merwe A. van der, Lublin D. M. et al. (1997) Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389: 636-639
152. 152 Schnitzer J. E., Oh P., Pinney E. and Allard J. (1994) Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127: 1217-1232
153. 153 Furuchi T. and Anderson R. G. W. (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273: 21009-21104
154. Sx Mol. Biol. Cell 7: 1225-1233
155. Sx. J. Biol. Chem. 268: 1225-1233
156. 156 Mumby S. M. and Muntz K. H. (1995) Receptor regulation and G protein palmitoylation. Biochem. Soc. Transact. 23: 156 160
157. 157 Shenoy-Scaria A. M., Gauen L. K., Kwong J., Shaw A. S. and Lublin D. M. (1993) Palmitoylation of an amino-terminal cysteine motif of protein kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol. Cell. Biol. 13: 6385-6392
158. S protein x subunit after activation by the β-adrenergic receptor or cholera toxin. J. Biol. Chem. 268: 23769-23772
159. 159 Liu P., Ying Y. S. and Anderson R. G. W. (1997) PDGF activates MAP kinase in isolated caveolae. Proc. Natl. Acad. Sci. USA 94: 13666-13670
160. 160 Li S., Seitz R. and Lisanti M. P. (1996) Phosphorylation of caveolin by Src tyrosine kinases: the alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem. 271: 3863-3868
161. 161 Koleske A. J., Baltimore D. and Lisanti M. P. (1995) Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92: 1381-1385
162. 162 Galbiati F., Volonte D., Engelman J. A., Watanabe G., Burk R., Pestell R. G. et al. (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17: 6633-6648
163. 163 Engelman J. A., Zhang X. L. and Lisanti M. P. (1998) Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett. 436: 403 410
164. 164 Macaulay S. L. and Larkins R. G. (1990) Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization. Cell. Signal. 2: 9-19
165. 165 Müller G., Rouveyre N., Crecclius A. and Bandlow W. (1998) Insulin signaling in the yeast Saccharomyces cerevisiae. 1. Stimulation of glucose metabolism and Snfl kinase by human insulin. Biochemistry 37: 8683 8695
166. 166 Müller G., Rouveyre N., Upshon C., Groß E. and Bandlow W. (1998) Insulin signaling in the yeast Saccharomyces cerevisiae. 2. Interaction of human insulin with a putative binding protein. Biochemistry 37: 8696 8704
167. 167 Müller G., Rouveyre N., Upshon C. and Bandlow W. (1998) Insulin signaling in the yeast Saccharomyces cerevisiae: induction of protein phosphorylation by human insulin. Biochemistry 37: 8705 8713
168. 168 Häring H., Obermaier B., Ermel B., Su Z., Mushack J., Rattenhuber E. et al. (1987) Insulin receptor kinase defects as a possible cause of cellular insulin resistance. Diabetes Metab. 13: 284 293
169. 169 Moller D. E. (ed.) (1993) Insulin Resistance. Wiley, New York
170. 170 Sinha M. K., Pories W. J., Flickinger E. G., Meelheim D. and Caro J. F. (1987) Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM. Diabetes 36: 620-625
171. 171 Le Marchand-Brustel Y., Gremeaux T., Ballolti R. and Van Obberghen E. (1985) Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature 315: 676 679
172. 172 Arner P., Pollare T., Lithell H. and Livingston J. N. (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437 440
173. 173 Freidenberg G. R., Tanti J. F., Van Obberghen E. and LeMarchand-Brustel Y. (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent subjects. J. Clin. Invest. 79: 240 250
174. 174 Caro J. F., Sinha M. K. and Raju S. J. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 79: 1330 1337
175. 175 Freidenberg G. R., Reichart D., Olefsky J. M. and Henry R. R. (1988) Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus: effect of weight loss. J. Clin. Invest. 82: 1398 1406
176. 176 Obermeier-Kusser B., White M. F., Pongratz D., Su Z., Ermel B., Mühlbacher C. et al. (1989) A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabeted mellitus. J. Biol. Chem. 264: 9497-9504
177. 177 Pratley R. E., Thompson D. B., Prochazka M., Baier L., Mott D., Ravussin E. et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima indians. J. Clin. Invest. 101: 1757 1764
178. 178 Kulkarni R. N., Brüning J. C., Winnay J. N., Postic C., Magnuson M. A. and Kahn C. R. (1999) Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96: 329 339